In collaboration with GLOBAL HEALTH SCIENCES, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. Training workshop

Similar documents
KENYA AIDS STRATEGIC FRAMEWORK 2014/ /2019

APPLICANT REQUEST FOR MATCHING FUNDS. IMPORTANT: To complete this form, refer to the Instructions for Matching Funds Requests.

Which Scale Up Strategies/Programmatic Mixes are most Cost-Effective? Iris Semini UNAIDS May 2018

HIV in key populations: the global context and agenda

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

Nairobi City s Progress Towards Ending the HIV Epidemic. Dr. Carol Ngunu-Gituathi Deputy Director, Health Services, NAIROBI

Strengthening the Evidence for HIV Investments: Allocative Efficiency of HIV Responses: Results and Experiences

PERFORMANCE INDICATOR REFERENCE SHEETS FOR KEY POPULATIONS

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project

High-Impact HIV Prevention (HIP) in San Francisco. San Francisco Department of Public Health September 17, 2014

Available In person Courses

2016 NYS HIV Quality of Care Review

World Health Organization. A Sustainable Health Sector

Zero HIV infections Zero HIV deaths Zero HIV stigma. Stephanie Cohen, MD, MPH on behalf of the Getting to Zero Consortium

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

Sexually Transmitted Infections in Vulnerable Groups. Kevin Rebe

GEORGIA STATEWIDE MSM STRATEGIC PLAN

Getting to Zero in California: Integration of HIV Prevention and Surveillance

California Department of Public Health (CDPH), Office of AIDS (OA) Monthly Report April 2018

New England HIV Implementation Science Network

Prevention targets & scorecard

Implementation of PrEP in Kenya

HIV and Sexual reproductive health integration: reaching adolescents and young people. What does this (the above) look like for key populations.

PrEP and Key populations: WHO guidelines & recommendations

HIV Prevention Prioritization & Implementation Brief: Anambra State

Translating Science to end HIV in Latin America and the Caribbean

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy F

As a result of this training, participants will be able to:

PROJECT BRIDGE: Differentiation of HIV Services for PWID in Harm Reduction Programs in Kazakhstan. Nabila El-Bassel, PhD Columbia University

Protecting and Promoting Health and Equity

Paediatric and Adolescent HIV Research Grant Programme

Sierra Leone. HIV Epidemiology Report 2016

Bruce D. Agins, MD MPH Medical Director, AIDS Institute Adherence 2017; Miami

USING EVIDENCE- INFORMED INTERVENTIONS TO IMPROVE HEALTH OUTCOMES AMONG PEOPLE LIVING WITH HIV

Public-Private Collaboration to Re-engage Out-of-Care Persons into HIV Care

Harm Reduction in Nigeria

HIV, HBV and HCV testing policy experiences and lessons learned.

HIV Partner Services in HIV Care Programs

Direct Clinical Services

Summary of Expected Insights from Oral PrEP Projects in Kenya. LVCT Health in partnership with FSG and AVAC

Comprehensive HIV/AIDS Resources and Linkages for Inmates (CHARLI) and Care Coordination (CC) Collaborative. Care Coordination

HIV Prevention Service Provider Survey 2014

Differentiated Care Improving Engagement and Retention in HIV Care. Meg Doherty, MD PhD MPH World Health Organization

Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

Using anti-hiv drugs for prevention

Structured Guidance for Postpartum Retention in HIV Care

Sex Work in Sub-Saharan Africa : Opportunities and Challenges

ViiV Healthcare s Position on Prevention in HIV

Regional program of the East Europe and Central Asia Union of PLWH within the framework of the Global Fund New Funding Model

HIV Prevention Prioritization & Implementation Brief: Kaduna State

AETC PRACTICE TRANSFORMATION BASELINE ORGANIZATIONAL ASSESSMENT

HIV Resource Allocations using AEM

Service Model: For Non-Clinical and Clinical Settings: HIV Testing. Agencies may employ evidence-based strategies, including the social network

Fulton County Board of Health Strategy to End the HIV Epidemic in Fulton County

ISHTAR - PROGRAMME REVIEW REPORT

Investing for Impact

WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-18-17AUZ]

Overcoming Structural Barriers to HIV Prevention

HIV Prevention Prioritization & Implementation Brief: Gombe State

About Project Sunrise

versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects

Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

Regional Collaboration to Optimize the Cascade: The Northwestern Public Health CFAR Consortium

IFMSA Policy Statement Ending AIDS by 2030

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Combination prevention: Public health and human rights imperatives

Women and PrEP: What are local health departments doing?

Government of Canada Federal AIDS Initiative Milestones

Ending the Epidemic in New York State

Ending the AIDS epidemic by 2030

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

Acceptability of HPTN 077. The George Washington University HPTN Clinical Research Site 16 June 2016

What we need to know: The role of HIV surveillance in ending the AIDS epidemic as a public health threat

HIV & AIDS IN SOUTH AFRICA: WHERE ARE WE AND WHAT ARE

Guyana Key Population Size Estimation Validation and Client Code Assessment

Strategic use of antiretroviral drugs to prevent HIV transmission

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

On-going Integrated Strategy Interventions to Maximize ART and PrEP Effectiveness in Peru

PEPFAR SOLUTIONS PLATFORM (BETA) WHAT WAS THE PROBLEM? WHAT IS THE SOLUTION?

HIV Prevention Prioritization & Implementation Brief: Lagos State

Prioritized research questions for adolescent HIV testing, treatment and service delivery

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

Overview and Status of PrEP in Kenya

NYC s PrEP Network. Julie Myers, MD, MPH New York City Department of Health and Mental Hygiene

NATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK

BUDGET AND RESOURCE ALLOCATION MATRIX

Global AIDS Response Progress Report Myanmar. National AIDS Programme

HIV Prevention Prioritization & Implementation Brief: Benue State

Adapting Treatment 2.0 in Viet Nam - Toward Universal and Sustainable Access -

Connecting the Community. Advancing the HIV Response in Baltimore and Jackson.

Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new

From Africa to Georgia: What We Have Learned From the Treatment for All Initiative

Protection and resilience: A simple checklist for why, where and how to coordinate HIV and child protection policy and programming

Supplementary Material Table 5. Ongoing PrEP studies among young key population, young people, and key populations. Age range. Study name and location

Transcription:

WHO COLLABORATING CENTRE FOR HIV STRATEGIC INFORMATION ANDRIJA ŠTAMPAR SCHOOL OF PUBLIC HEALTH, SCHOOL OF MEDICINE UNIVERSITY OF ZAGREB John D. Rockefeller Street No. 4, 10 000 Zagreb, Croatia Phone: + 385 1 45 90 142/ 45 90 100; Fax: +385 1 46 84 212 www.whohub-zagreb.org http://mse.mef.unizg.hr/ In collaboration with GLOBAL HEALTH SCIENCES, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Training workshop Reaching the 90-90-90 targets in key and priority populations: Cascade-driven programmes to improve engagement in HIV prevention and care 15-19 October 2018, Zagreb, Croatia Learning Objectives Globally, new infections among key populations (KPs) and their sexual partners account for 36% of all new HIV infections. The HIV response for KPs, including men who have sex with men (MSM), female sex workers (FSW), people who inject drugs (PWID), prisoners and transgender individuals, will play a central role in ending the AIDS epidemic by 2030. However, there remains suboptimal alignment of surveillance and programmatic data, as well as routinely collected medical records to facilitate the reporting of the 90-90-90 indicators for HIV among KPs. The course will outline key strategies that should be utilized to reach 90-90-90 targets in key and priority populations including: Understanding the epidemic - knowing where and how many KP members to reach Implementation of evidence-based interventions Conducting HIV care cascade analysis and other methods of programme evaluation Introductory presentations will outline how to construct HIV care cascades in KPs using survey and/or programmatic data. The course will address opportunities for improving the value of integrated bio-behavioral surveys (IBBS) for programme improvement, such as characterizing those reached by the survey, but missed by programmes; using the Internet for recruitment of survey participants, measuring gaps in service delivery, and measuring indicators of the cascade of HIV prevention and care. 1

Methods of population size estimation, including programmatic mapping will be described as well, as they provide critical information that helps programme planners to understand the location, typologies and operational dynamics of a target population. The next part of the course will summarize packages of HIV interventions for KPs, focusing on those that enable achieving the epidemic control pre-exposure prophylaxis (PrEP), novel approaches to HIV testing (including HIV self-testing, partner notification), proactive enrolment into HIV care and interventions that support early ART initiation, retention and viral load suppression (for example, application of ehealth to improve linkage to and retention in HIV clinical care, peer-delivered linkage case management and same day ART initiation, differentiated care models for KPs, etc). Presentations will also outline components of programmes that aim to engage heterosexual men since in many settings men are more likely to present late to HIV care, and have worse adherence and viral load outcomes. The third part of the course will present methods of evaluation of HIV programmes, from cross-sectional surveys to randomized trials and other experimental designs. The issues to be addressed include the selection of the study population for evaluation studies, sampling, statistical inference and measuring outcomes and impact. The key part of the course is group/individual work. Participants may choose among the following options: Option A construct an HIV cascade for a KP (FSW, MSM, PWID, etc.) using most recent data that participants will bring from their countries; and recommend interventions to close the gaps in the cascade Option B develop a proposal for an intervention/programme in order to improve specific outcomes in the continuum of HIV care (HIV testing, linkage to care, ART initiation, retention) Option c develop an evaluation plan for a programme/intervention (HIV testing, linkage to care, ART initiation, retention, viral load supression, etc) Participants will present the results of this work on the final day of the course. Course objectives: Illustrate approaches for constructing and interpreting findings from the cascade analysis Learn how to use cascade data to target performance improvement and provide recommendations for the most effective and feasible interventions Outline components of comprehensive HIV programmes for MSM, PWID and FSW, including evidence on effectiveness of novel interventions specific for each KP (proactive enrollment in HIV prevention and treatment using peer-driven linkage, e-health interventions, home-based and community interventions, etc) and crosscutting interventions (PrEP and PEP) Illustrate different service delivery (DSD) methods stand-alone clinics, clinics within DICs, mobile/outreach services, private clinics Describe methods used to evaluate interventions (programme data, crosssectional studies, cohort studies, randomized control trials, stepped wedge designs, preference trials and randomized consent designs, pre-post intervention designs, etc.) in KPs 2

Teaching Methods The course consists of lectures, exercises and case studies. It is designed to provide participants with practical skills and knowledge in development, implementation and evaluation (including cascade analysis) of HIV interventions in KPs. Target Audience Professionals working in HIV surveillance and in planning, implementation and evaluation of HIV prevention and treatment interventions Lecturers Professor George W. Rutherford, MD, Global Health Sciences, University of California, San Francisco, USA Associate professor Ivana Bozicevic, MD, DrPH, WHO Collaborating Centre for HIV Strategic Information, School of Medicine, University of Zagreb, Croatia Zoran Dominkovic, WHO Collaborating Centre for HIV Strategic Information, School of Medicine, University of Zagreb, Croatia Course organizers Lucija Sikic and Jelena Mihaljevic, WHO Collaborating Centre for HIV Strategic Information; training@snz.hr The course fee is 1000 USD and includes lunches and coffee breaks during the course and course materials. The fee should be paid by October 1 st, 2018. 3

Programme Reaching the 90-90-90 Targets in Key and Priority Populations: Cascade-driven Programmes to Improve Engagement in HIV Prevention and Care 15 October 2018 9.00-9.30 Welcome and Introductions 9.30-10.10 Tracking progress towards the 90-90-90 target in key and vulnerable populations 10.10-11.00 Data requirements for construction of HIV care cascades in key populations 11.00-11.20 Break 11.20-12.30 12.30-13.30 Lunch 13.30-14.45 Estimating the number of key populations living with HIV using the ECDC HIV modelling tool Population size estimation methods (1): multiplier, capture-recapture and network-scale up 14.45-15.30 Exercise (1): Constructing an HIV care cascade in key populations 15.30-15.50 Break 15.50-16.45 Country presentations (participants) 16 October 2018 9.00-10.00 10.00-10.50 10.50-11.10 Break 11.10-12.00 Population size estimation methods (2): Programmatic mapping for planning service delivery Improving the value of integrated bio-behavioural surveys for programme improvement Exercise (2): Assessing reasons for HIV service gaps across the HIV care cascade in key populations Overview of comprehensive HIV programmes in PWID (1): Examples of topics: Integration of HIV care and addiction treatment; peer-led community-based approaches to increase HIV testing and treatment services; peer navigation/case management services; prevention and treatment services in correctional settings 13.50-14.40 Overview of comprehensive HIV programmes in PWID (2): 14.40-15.15 Introduction to group/individual work (either on the cascade analysis, development of an intervention for KPs, or intervention/ programme evaluation) 15.15-15.30 Break 15.30-16.30 Group/ individual work 4

17 October 2018 9.00-10.00 Overview of comprehensive HIV programmes in MSM (1): Examples of topics: PrEP; stigma reduction in health care settings; using social networking sites, web-based videos and text messaging to increase testing and retention in care; cased-based strengths management to increase ART initiation and retention 10.00-10.50 Overview of comprehensive HIV programmes in MSM (2): 10.50-11.10 Break 11.10-12.00 Exercise Overview of comprehensive HIV programmes in FSW (1): Examples of topics: community mobilization and empowerment; violence prevention; PrEP; peer outreach to increase HIV testing; community groups and peer navigators to support linkage to care, ART retention; follow-up appointments 13.50-14.50 Overview of comprehensive HIV programmes in FSW (2): 14.50-15.40 Increasing male involvement in the HIV response in countries with substantial epidemics in heterosexual men 15.40-16.45 Group/ individual work 16.00 Break 18 October 2018 9.00-9.50 Introduction to HIV programme evaluation Using observational study design in evaluation: cross-sectional studies 9.50-10.40 Using observational study design in evaluation: cohort studies 10.40-11.00 Break 11.00-12.00 Using experimental study design in evaluation HIV data synthesis as a programme evaluation tool: examples from generalised and concentrated HIV epidemics 13.50-16.30 Group/ individual work 15.15 Break 19 October 2018 9.00-10.20 Presentations of group/ individual work 10.20-10.40 Break 10.40-12.30 Presentations of group/ individual work 12.30-13.00 Evaluations and closure 13.00-14.00 Lunch 5